New technologies for vaccine development

Kellathur N. Srinivasan, Vladimir Brusic, Thomas J. August

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

(Table Presented) Vaccines offer protection against infectious diseases, but the successes from the years of development have been mixed. Some diseases have been effectively controlled or eradicated through vaccination, whereas treatments for a number of diseases, especially the reemerging diseases, currently do not exist. Improved understanding of pathogen variability as well as of the diversity of the human immune system, plus technological advances in genetic and molecular biology provide better insights in the host-pathogen interaction and new avenues for vaccine development. In this article we discuss the latest trends in vaccine research with focus on epitope-based DNA vaccines and trafficking components for efficient vaccine delivery. These approaches are promising in dealing with host and pathogen diversity as well as with diversity within human populations.

Original languageEnglish
Pages (from-to)383-392
Number of pages10
JournalDrug Development Research
Volume62
Issue number4
DOIs
Publication statusPublished - Aug 2004
Externally publishedYes

Fingerprint

Pathogens
Vaccines
Technology
Host-Pathogen Interactions
DNA Vaccines
Molecular biology
Immune system
Communicable Diseases
Epitopes
Molecular Biology
Immune System
Vaccination
Research
Population
Therapeutics

Keywords

  • Bioinformatics
  • Hot spots
  • T-cell epitopes
  • Vaccines

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Srinivasan, K. N., Brusic, V., & August, T. J. (2004). New technologies for vaccine development. Drug Development Research, 62(4), 383-392. https://doi.org/10.1002/ddr.10393

New technologies for vaccine development. / Srinivasan, Kellathur N.; Brusic, Vladimir; August, Thomas J.

In: Drug Development Research, Vol. 62, No. 4, 08.2004, p. 383-392.

Research output: Contribution to journalArticle

Srinivasan, KN, Brusic, V & August, TJ 2004, 'New technologies for vaccine development', Drug Development Research, vol. 62, no. 4, pp. 383-392. https://doi.org/10.1002/ddr.10393
Srinivasan, Kellathur N. ; Brusic, Vladimir ; August, Thomas J. / New technologies for vaccine development. In: Drug Development Research. 2004 ; Vol. 62, No. 4. pp. 383-392.
@article{9056f2f373864e41a99588acf5ce2ea3,
title = "New technologies for vaccine development",
abstract = "(Table Presented) Vaccines offer protection against infectious diseases, but the successes from the years of development have been mixed. Some diseases have been effectively controlled or eradicated through vaccination, whereas treatments for a number of diseases, especially the reemerging diseases, currently do not exist. Improved understanding of pathogen variability as well as of the diversity of the human immune system, plus technological advances in genetic and molecular biology provide better insights in the host-pathogen interaction and new avenues for vaccine development. In this article we discuss the latest trends in vaccine research with focus on epitope-based DNA vaccines and trafficking components for efficient vaccine delivery. These approaches are promising in dealing with host and pathogen diversity as well as with diversity within human populations.",
keywords = "Bioinformatics, Hot spots, T-cell epitopes, Vaccines",
author = "Srinivasan, {Kellathur N.} and Vladimir Brusic and August, {Thomas J.}",
year = "2004",
month = "8",
doi = "10.1002/ddr.10393",
language = "English",
volume = "62",
pages = "383--392",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - New technologies for vaccine development

AU - Srinivasan, Kellathur N.

AU - Brusic, Vladimir

AU - August, Thomas J.

PY - 2004/8

Y1 - 2004/8

N2 - (Table Presented) Vaccines offer protection against infectious diseases, but the successes from the years of development have been mixed. Some diseases have been effectively controlled or eradicated through vaccination, whereas treatments for a number of diseases, especially the reemerging diseases, currently do not exist. Improved understanding of pathogen variability as well as of the diversity of the human immune system, plus technological advances in genetic and molecular biology provide better insights in the host-pathogen interaction and new avenues for vaccine development. In this article we discuss the latest trends in vaccine research with focus on epitope-based DNA vaccines and trafficking components for efficient vaccine delivery. These approaches are promising in dealing with host and pathogen diversity as well as with diversity within human populations.

AB - (Table Presented) Vaccines offer protection against infectious diseases, but the successes from the years of development have been mixed. Some diseases have been effectively controlled or eradicated through vaccination, whereas treatments for a number of diseases, especially the reemerging diseases, currently do not exist. Improved understanding of pathogen variability as well as of the diversity of the human immune system, plus technological advances in genetic and molecular biology provide better insights in the host-pathogen interaction and new avenues for vaccine development. In this article we discuss the latest trends in vaccine research with focus on epitope-based DNA vaccines and trafficking components for efficient vaccine delivery. These approaches are promising in dealing with host and pathogen diversity as well as with diversity within human populations.

KW - Bioinformatics

KW - Hot spots

KW - T-cell epitopes

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=11344290828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344290828&partnerID=8YFLogxK

U2 - 10.1002/ddr.10393

DO - 10.1002/ddr.10393

M3 - Article

VL - 62

SP - 383

EP - 392

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 4

ER -